Literature DB >> 16755518

Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling.

L Hameetman1, L B Rozeman, M Lombaerts, J Oosting, A H M Taminiau, A-M Cleton-Jansen, J V M G Bovée, P C W Hogendoorn.   

Abstract

Hedgehog (HH) signalling is important for specific developmental processes, and aberrant, increased activity has been described in various tumours. Disturbed HH signalling has also been implicated in the hereditary syndrome, Multiple Osteochondromas. Indian Hedgehog (IHH), together with parathyroid hormone-like hormone (PTHLH), participates in the organization of growth plates in long bones. PTHLH signalling is absent in osteochondromas, benign tumours arising adjacent to the growth plate, but is reactivated when these tumours undergo malignant transformation towards secondary peripheral chondrosarcoma. We describe a gradual decrease in the expression of Patched (PTCH) and glioma-associated oncogene homologue 1 (GLI1) (both transcribed upon IHH activity), and GLI2 with increasing malignancy, suggesting that IHH signalling is inactive and PTHLH signalling is IHH independent in secondary peripheral chondrosarcomas. cDNA expression profiling and immunohistochemical studies suggest that transforming growth factor-beta (TGF-beta)-mediated proliferative signalling is active in high-grade chondrosarcomas since TGF-beta downstream targets were upregulated in these tumours. This is accompanied by downregulation of energy metabolism-related genes and upregulation of the proto-oncogene jun B. Thus, the tight regulation of growth plate organization by IHH signalling is still seen in osteochondroma, but gradually lost during malignant transformation to secondary peripheral chondrosarcoma and subsequent progression. TGF-beta signalling is stimulated during secondary peripheral chondrosarcoma progression and could potentially regulate the retained activity of PTHLH. Copyright 2006 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755518     DOI: 10.1002/path.2008

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  26 in total

Review 1.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

2.  Detection of exostosin glycosyltransferase gene mutations in patients with non-hereditary osteochondromas of the mandibular condyle.

Authors:  Qin Zhou; Chi Yang; Min-Jie Chen; Ling-Zhi Li
Journal:  Mol Clin Oncol       Date:  2016-07-08

3.  No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.

Authors:  Christianne M A Reijnders; Cathelijn J F Waaijer; Andrew Hamilton; Emilie P Buddingh; Sander P D Dijkstra; John Ham; Egbert Bakker; Karoly Szuhai; Marcel Karperien; Pancras C W Hogendoorn; Sally E Stringer; Judith V M G Bovée
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

Review 4.  Benefits of molecular pathology in the diagnosis of musculoskeletal disease : Part II of a two-part review: bone tumors and metabolic disorders.

Authors:  Adrienne M Flanagan; David Delaney; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2009-08-11       Impact factor: 2.199

5.  Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.

Authors:  Yvonne M Schrage; Liesbeth Hameetman; Karoly Szuhai; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.

Authors:  Cathelijn J F Waaijer; Carlos E de Andrea; Andrew Hamilton; Jolieke G van Oosterwijk; Sally E Stringer; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2012-08-18       Impact factor: 4.064

7.  Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma.

Authors:  Megan E Roche; Zhao Lin; Diana Whitaker-Menezes; Tingting Zhan; Karoly Szuhai; Judith V M G Bovee; John A Abraham; Wei Jiang; Ubaldo Martinez-Outschoorn; Atrayee Basu-Mallick
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-10       Impact factor: 5.187

Review 8.  MicroRNA-mediated gene regulations in human sarcomas.

Authors:  Subbaya Subramanian; Reena V Kartha
Journal:  Cell Mol Life Sci       Date:  2012-08-25       Impact factor: 9.261

Review 9.  Biological mechanisms of bone and cartilage remodelling--genomic perspective.

Authors:  F Borovecki; N Pecina-Slaus; S Vukicevic
Journal:  Int Orthop       Date:  2007-07-03       Impact factor: 3.075

10.  A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes.

Authors:  Salvatore Romeo; Karoly Szuhai; Isao Nishimori; Marije Ijszenga; Pauline Wijers-Koster; Antonie H M Taminiau; Pancras C W Hogendoorn
Journal:  BMC Cancer       Date:  2009-11-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.